Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI

Abroad (travel likely)RecruitingPHASE3

Conditions

Colorectal Cancer · Colorectal Liver Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hôpital Kremlin Bicêtre, Paris, Île-de-France Region, France
Contact: Study coordinator (stéphane BENOIST, MHD, PHD) · Stephane.benoist@aphp.fr · +33 1 45 21 34 72
Contact: Study coordinator (Antoine BROUQUET) · Anoine.brouquet@aphp.fr · +33 1 45 21 34 70

Study leads

Eric VICAUT, MHD, PHD
Study Chair
APHP
Eric VICAUT, MHD, PHD
Principal Investigator
APHP

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases

Colorectal Cancer · Liver Metastases

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Metastatic Colorectal Adenocarcinoma · Stage IV Colorectal Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE3

Kingman, United States · Phoenix, United States

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Liver Metastases · Colorectal Cancer · Anal Canal Cancer

Abroad (travel likely)RecruitingPHASE2

São Paulo, Brazil

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Rectal Cancer

Abroad (travel likely)RecruitingPHASE2

Richmond, United States · Richmond, United States